La Jolla, CA, United States of America

Carol A Fulcher



Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 204(Granted Patents)


Company Filing History:


Years Active: 1982-1998

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carol A. Fulcher

Introduction

Carol A. Fulcher is a prominent inventor based in La Jolla, California, known for her significant contributions to the field of biotechnology. With a remarkable portfolio of 16 patents, she has made strides in the development of therapeutic agents related to blood coagulation.

Latest Patents

Among her latest patents are groundbreaking discoveries such as Factor VIII coagulant polypeptides and monoclonal antibodies to them. These polypeptides exhibit high specific VIII:C coagulant activity, which is crucial for treating hemophilia. Additionally, she has developed peptides that inhibit the binding of von Willebrand Factor to Factor VIII, along with monoclonal antibodies capable of specifically binding to the region of von Willebrand Factor containing the Factor VIII binding domain. Furthermore, her work includes improved methods of preparing Factor VIII, enhancing the efficiency of this vital therapeutic protein.

Career Highlights

Throughout her career, Carol has worked with esteemed organizations such as the Scripps Clinic and Research Foundation and Rorer Biotechnology Inc. Her innovative research has not only advanced scientific understanding but has also paved the way for new treatment options in hematology.

Collaborations

Carol has collaborated with notable colleagues, including Theodore S. Zimmerman and Paul A. Foster, contributing to a rich exchange of ideas and expertise in her field.

Conclusion

Carol A. Fulcher's contributions to biotechnology and her innovative patents have significantly impacted the medical community, particularly in the area of blood coagulation therapies. Her work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…